Stephen Squinto
Listed on 9 Form D filings across 6+ issuers
· Director, Executive Officer
Associated issuers
- 270 Healthcare Growth Fund I (LUX) SCSp-RAIF CIK 2066084 · N4
- 270 Healthcare Growth Fund I LP CIK 2018060 · NY
- 270 Life Sciences Private Capital Fund II (Cayman) LP CIK 2154213 · NY
- 270 Life Sciences Private Capital Fund II (US) LP CIK 2154207 · NY
- Averna Therapeutics Inc. CIK 2020048 · MA
- Enlaza Therapeutics, Inc. CIK 1852950 · CA
Filings (9)
-
270 Healthcare Growth Fund I (LUX) SCSp-RAIFD · Sep 29, 2026 · N4 · Pooled Investment Fund
-
270 Healthcare Growth Fund I LPD · Sep 29, 2026 · NY · Pooled Investment Fund
-
270 Life Sciences Private Capital Fund II (Cayman) LPD · Sep 16, 2026 · NY · Pooled Investment Fund
-
270 Life Sciences Private Capital Fund II (US) LPD · Sep 16, 2026 · NY · Pooled Investment Fund
-
Averna Therapeutics Inc.D · Mar 20, 2026 · MA · Other Health Care$85MView filing →
-
270 Healthcare Growth Fund I (LUX) SCSp-RAIFD · Sep 29, 2025 · N4 · Pooled Investment Fund
-
270 Healthcare Growth Fund I LPD · Sep 29, 2025 · NY · Pooled Investment Fund
-
Enlaza Therapeutics, Inc.D · Sep 11, 2025 · CA · Pharmaceuticals$15MView filing →
-
Averna Therapeutics Inc.D · Apr 21, 2025 · MA · Other Health Care$85MView filing →